| 发明名称 |
Peroral formulation of dienogest and ethinylestradiol for contraception |
| 摘要 |
<p>Peroral dosage form for contraception comprises 17 alpha -cyanomethyl-17 beta -hydroxyestra-4,9-diene-3-one (dienogest) (= 2 mg) and 17 alpha -ethinylestradiol (ethinylestradiol) (less than 0.03 mg), where the crystalline active agent dienogest is contained with an average particle size of 30-270 mu m. ACTIVITY : Contraceptive; Antiseborrheic; Dermatological. MECHANISM OF ACTION : None given.</p> |
| 申请公布号 |
EP1886694(A1) |
申请公布日期 |
2008.02.13 |
| 申请号 |
EP20060016694 |
申请日期 |
2006.08.10 |
| 申请人 |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
发明人 |
GERECKE, HAGEN;LADWIG, RALF;WIESINGER, HERBERT;FRICKE, SABINE;BUSKE, ALEXANDER |
| 分类号 |
A61K45/06;A61K9/16;A61K9/20;A61K31/567;A61K31/569;A61P15/12;A61P15/18 |
主分类号 |
A61K45/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
